Clinical Trials

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Triple Negative Breast Neoplasms

NCT05269381 2026-03-12

PNeoVCA

Phase 1/2 Recruiting

132 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinosarcoma, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Carcinoma, Merkel Cell, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT05455658 2025-10-24

STEMVAC in Patients With Early Stage Triple Negative Breast Cancer

Phase 2 Active not recruiting

33 enrolled

Triple Negative Breast Neoplasms

NCT00436254 2025-04-06

Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer

66 enrolled

BreastGynecologic

Carcinoma, Ovarian Epithelial, Breast Neoplasms

NCT02780401 2024-09-19

WOKVAC

32 enrolled 13 charts

Breast Neoplasms

NCT04197687 2023-12-18

TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery

Phase 2 Unknown

480 enrolled

Phase 2 Active not recruiting

Breast Neoplasms

NCT03012100 2023-01-13

Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer

280 enrolled

Unilateral Breast Neoplasms, Breast Neoplasms, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00343109 2020-02-12

Vaccine Therapy in Treating Patients Receiving Trastuzumab For HER2-Positive Stage IIIB-IV Breast Cancer

38 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT01355393 2020-02-10

Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer

Phase 1/2 Completed

50 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT00079157 2020-02-05

Vaccine Plus Montanide ISA-51 and Sargramostim in Treating Patients With Stage IV Breast Cancer

28 enrolled

Breast Neoplasms

NCT02276300 2019-11-20

HER2

2 enrolled

BreastGastrointestinal

Breast Neoplasms, Stomach Neoplasms

NCT00254592 2019-02-28

Neoadjuvant Treatment of Breast Cancer

43 enrolled 7 charts

Breast Neoplasms

NCT00003002 2019-02-27

HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung Cancer

BreastGynecologicThoracic

60 enrolled

Adenocarcinoma of Lung, Carcinoma, Ovarian Epithelial, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Ovarian Neoplasms

NCT00640861 2018-10-31

Vaccine Therapy in Treating Patients With Previously Treated Stage II or Stage III Breast Cancer

Phase EARLY_PHASE1 Completed

45 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00266110 2018-09-12

Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

17 enrolled 9 charts

Breast Neoplasms

NCT00005023 2017-11-30

Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Cancer

BreastGynecologicThoracic

Adenocarcinoma of Lung, Carcinoma, Ovarian Epithelial, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Ovarian Neoplasms

NCT00003199 2017-07-12

Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer

50 enrolled 11 charts

Breast Neoplasms, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

NCT00791037 2017-05-25

Vaccine Therapy in Treating Patients With Stage IV Breast Cancer

Phase 1/2 Completed

23 enrolled 9 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00027807 2016-02-17

Biological Therapy in Treating Women With Stage IV Breast Cancer

6 enrolled

Breast Neoplasms, Carcinoma, Ductal, Breast

NCT00022230 2015-05-05

Combination Chemotherapy Plus Biological Therapy in Treating Patients With Stage II or Stage III Breast Cancer

Phase 1/2 Withdrawn

Breast Neoplasms

NCT00429104 2012-12-06

Herceptin and GM-CSF for Metastatic Breast Cancer

18 enrolled 4 charts

Breast Neoplasms

NCT00003125 2011-03-24

Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors

BreastGastrointestinalThoracic

24 enrolled

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT00003269 2011-01-10

Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors

BreastDermatologicGynecologicLymphoidOther hematologic neoplasmThoracic

20 enrolled

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Burkitt Lymphoma, Carcinoma, Non-Small-Cell Lung, Hodgkin Disease, Lung Neoplasms, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Ovarian Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Drug-Related Side Effects and Adverse Reactions

NCT00003972 2010-04-02

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer

Phase 3 Completed

280 enrolled